{
    "eid": "2-s2.0-85160336301",
    "title": "Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand",
    "cover-date": "2023-05-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "anti-SARS-CoV-2 IgG",
        "BNT162b2",
        "COVID-19",
        "Delta",
        "hybrid immunity",
        "long COVID in children",
        "neutralizing antibody titer",
        "Omicron",
        "post COVID-19 conditions",
        "SARS-CoV-2 infection"
    ],
    "authors": [
        "Muttharat Jarupan",
        "Watsamon Jantarabenjakul",
        "Peera Jaruampornpan",
        "Jarujan Subchartanan",
        "Chayapa Phasomsap",
        "Taweesak Sritammasiri",
        "Sapphire Cartledge",
        "Pintip Suchartlikitwong",
        "Suvaporn Anugulruengkitt",
        "Surinda Kawichai",
        "Thanyawee Puthanakit"
    ],
    "citedby-count": 0,
    "ref-count": 29,
    "ref-list": [
        "Long-COVID in children and adolescents: A systematic review and meta-analyses",
        "The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis",
        "Long-term physical, mental and social health effects of COVID-19 in the pediatric population: A scoping review",
        "Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection",
        "Robust and durable serological response following pediatric SARS-CoV-2 infection",
        "Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19",
        "Omicron infection enhances Delta antibody immunity in vaccinated persons",
        "SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses",
        "Protection against SARS-CoV-2 after COVID-19 Vaccination and Previous Infection",
        "Hybrid immunity, COVID-19 vaccine responses provide insights into how the immune system perceives threats",
        "Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose",
        "Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers, Israel, December 2020 to January 2021",
        "Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination",
        "Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine",
        "A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction",
        "A serological assay to detect SARS-CoV-2 seroconversion in humans",
        "Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "Prevalence and clinical presentation of long COVID in children: A systematic review",
        "Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19",
        "Long COVID symptoms and duration in SARS-CoV-2 positive children\u2014A nationwide cohort study",
        "Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum",
        "Effects of Vaccination and Previous Infection on Omicron Infections in Children",
        "Immunogenicity of a Fractional Dose of mRNA BNT162b2 COVID-19 Vaccine for Primary Series and Booster Vaccination among Healthy Adolescents"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Birmingham",
            "@id": "60172647",
            "affilname": "Birmingham Medical School",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60172647",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadapiseksompotch Research Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}